@article{fdi:010088257,
  title = {{B}iomarkers : can they really guide our daily practice ?},
  author = {{T}sangaris, {I}. and {A}ntonakos, {N}. and {F}antoni, {M}. and {K}aplanski, {G}. and {K}yriazopoulou, {E}. and {V}eas, {F}rancisco and {C}lemens, {M}.},
  editor = {},
  language = {{ENG}},
  abstract = {{O}ptimal management of septic patients requires accurate assessment of both current severity status and prognosis. {S}ince the 1990s, substantial advances have been made in the use of circulating biomarkers for such assessments. {T}his summary of the session on "{B}iomarkers: can they really use guide our daily practice?" presented at the 2021 {WEB}-{CONFERENCE} {OF} {THE} {EUROPEAN} {SHOCK} {SOCIETY}, 6 {N}ovember 2021. {T}hese biomarkers include ultrasensitive detection of bacteremia, circulating soluble urokina-type plasminogen activator receptor (su{PAR}), {C}-reactive protein ({CRP}) and ferritin and procalcitonin. {I}n addition, the potential application of novel multiwavelength optical biosensor technology allows noninvasive monitoring of multiple metabolites that can be used to assess severity and prognosis in septic patients. {T}he application these biomarkers and improved technologies provide the potential for improved personalized management of septic patients.},
  keywords = {{C}-reactive protein ({CRP}) ; ferritin ; procalcitonin ({PCT}) and soluble urokinase plasminogen activator receptor (su{PAR}) ; sepsis ; biomarkers},
  booktitle = {},
  journal = {{S}hock},
  volume = {59},
  numero = {{N}o 3, {S}uppl. 1},
  pages = {16--20},
  ISSN = {1073-2322},
  year = {2023},
  DOI = {10.1097/shk.0000000000001957},
  URL = {https://www.documentation.ird.fr/hor/fdi:010088257},
}